Renata Ltd (RNTL)

Currency in BDT
448.60
+4.00(+0.90%)
Closed·
RNTL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
445.00458.40
52 wk Range
372.00548.00
Key Statistics
Prev. Close
503.4
Open
445
Day's Range
445-458.4
52 wk Range
372-548
Volume
22.63K
Average Volume (3m)
35.91K
1-Year Change
-11.5362%
Book Value / Share
313.48
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RNTL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
646.00
Upside
+44.00%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility

Renata Ltd News & Analysis

Show more

Renata Company Profile

Renata PLC manufactures, markets, and distributes pharmaceuticals, animal health medicines, oncology-based, agro-based, poultry, and consumer products in Bangladesh. The company offers generic products, including amantadine, clindamycin, clindamycin, colchicine, dipyridamole, escitalopram, fludrocortisone acetate, hydrocortisone, prednisolone, propylthiouracil, sertraline hydrochloride, terbinafine, and topiramate tablet and capsules. It also offers specialty products, such as SHK-024, an antidepressant, and SHK 007, to reduce toxicity in pediatrics. In addition, it provides animal health products. The company was formerly known as Pfizer Laboratories (Bangladesh) Limited and changed its name to Renata Limited in 1993. Renata PLC was incorporated in 1972 and is headquartered in Dhaka, Bangladesh.

Employees
8366

Compare RNTL to Peers and Sector

Metrics to compare
RNTL
Peers
Sector
Relationship
P/E Ratio
20.1x10.1x−0.5x
PEG Ratio
−1.410.140.00
Price/Book
1.4x1.5x2.6x
Price / LTM Sales
1.2x3.0x3.2x
Upside (Analyst Target)
45.3%35.3%47.3%
Fair Value Upside
Unlock0.1%6.7%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 646.00
(+44.00% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 22.11%
Dividend Yield
1.28%
Industry Median 3.97%
Annualised payout
5.50
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Feb 03, 2026
EPS / Forecast
7.11 / 5.64
Revenue / Forecast
10.93B / 10.70B
EPS Revisions
Last 90 days

Renata (RNTL) Income Statement & Profits

FAQ

What Is the Renata (RNTL) Share Price Today?

The Renata stock price today is 448.60 BDT.

What Stock Exchange Does Renata (RNTL) Trade On?

Renata is listed and trades on the Dhaka Stock Exchange.

What Is the Ticker (Stock Symbol) for Renata?

The stock symbol (also called a 'ticker') for Renata is "RNTL."

Does Renata Pay Dividends? What’s The Current RNTL Dividend Yield?

Yes, RNTL Pays Dividends to its Shareholders. The current Renata dividend yield is 1.28%.

What Is the Current Renata Market Cap?

As of today, Renata market cap is 51.45B BDT.

What Is Renata's (RNTL) Earnings Per Share (TTM)?

The Renata EPS is currently 22.11 (Trailing Twelve Months).

When Is the Next Renata Earnings Date?

Renata's next earnings report will be released on 23/04/2026.

Is RNTL a Buy or Sell From a Technical Analyst Perspective?

Based on today's Renata moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Renata Stock Split?

Renata has split 21 times. (See the RNTL stock split history page for full effective split date and price information.)

How Many Employees Does Renata Have?

Renata has 8366 employees.

What is the current trading status of Renata (RNTL)?

As of 03/03/2026, Renata (RNTL) is trading at a price of 448.60 BDT, with a previous close of 503.40 BDT. The stock has fluctuated within a day range of 445.00 BDT to 458.40 BDT, while its 52-week range spans from 372.00 BDT to 548.00 BDT.

What Is Renata (RNTL) Price Target According to Analysts?

The average 12-month price target for Renata is 646.00 BDT, with a high estimate of 739 BDT and a low estimate of 553 BDT. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +44.00% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.